SCHEMBL25823736

SCHEMBL25823736

CN(C)CC(n1c2ccccc2c2ccccc21)C(C)(C)C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 3/20 0.49
SLC6A2 P23975 2/20 0.38
SLC6A4 P31645 2/20 0.38
SLC6A3 Q01959 2/20 0.38
HTR2A P28223 1/20 0.37
HRH1 P35367 1/20 0.37
TSHR P16473 1/20 0.36
NPY1R P25929 1/20 0.36
NPY2R P49146 1/20 0.36
GPR3 P46089 1/20 0.36
ALDH1A1 P00352 2/20 0.36
PER2 O15055 2/20 0.36
CRY1 Q16526 2/20 0.36
CRY2 Q49AN0 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
CYP2C19 P33261 2/20 0.35
CYP1A2 P05177 1/20 0.35
CHRM2 P08172 1/20 0.35
CHRNA7 P36544 1/20 0.35
NPY5R Q15761 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13954491 0.79 GPR3 (0.39) DNM1TSHRNPY1RNPY2RGPR3
SCHEMBL23680180 0.77 GPR3 (0.38) DNM1TSHRGPR3ALDH1A1TDP1
SCHEMBL18445707 0.77 GPR3 (0.38) SLC6A2TSHRNPY1RNPY2RGPR3
SCHEMBL19780659 0.73 GPR3 (0.40) DNM1TSHRNPY1RNPY2RGPR3
SCHEMBL18597053 0.71 GPR3 (0.46) DNM1SLC6A2TSHRGPR3TDP1
SCHEMBL18758900 0.70 GPR3 (0.44) DNM1TSHRGPR3ALDH1A1TDP1
SCHEMBL21523922 0.68 GPR3 (0.43) DNM1TSHRGPR3TDP1CYP2C19
SCHEMBL17070058 0.67 GPR3 (0.46) DNM1TSHRNPY1RNPY2RGPR3
SCHEMBL24899628 0.67 GPR3 (0.34) DNM1TSHRNPY1RNPY2RGPR3
SCHEMBL22785992 0.67 ALDH1A1 (0.35) DNM1TSHRNPY1RNPY2RGPR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212136-A1 CURABLE RESIN COMPOSITION, CURED PRODUCT, DIFFRACTIVE OPTICAL ELEMENT, AND MULTILAYER DIFFRACTIVE OPTICAL ELEMENT FUJIFILM CORPORATION (JP) 2023-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230212136-A1 CURABLE RESIN COMPOSITION, CURED PRODUCT, DIFFRACTIVE OPTICAL ELEMENT, AND MULTILAYER DIFFRACTIVE OPTICAL ELEMENT TERB1, RER1, LARP1 DNM1 4661/4885SLC6A2 4406/4885SLC6A4 3854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.